Subpopulation of small-cell lung cancer cells expressing CD133 and CD87 show resistance to chemotherapy

Classical resistance mechanisms

(2011) W. Jäger   INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS

Molecular mechanisms of cisplatin resistance

(2011) L Galluzzi et al.   ONCOGENE

CD13 is a therapeutic target in human liver cancer stem cells

(2010) Naotsugu Haraguchi et al.   JOURNAL OF CLINICAL INVESTIGATION

Both CD133+and CD133−subpopulations of A549 and H446 cells contain cancer-initiating cells

(2009) Xiangjiao Meng et al.   CANCER SCIENCE

Urokinase Plasminogen Activator Receptor Choreographs Multiple Ligand Interactions: Implications for Tumor Progression and Therapy

(2008) A. P. Mazar   CLINICAL CANCER RESEARCH

Stem Cell Marker CD133 Affects Clinical Outcome in Glioma Patients

(2008) F. Zeppernick et al.   CLINICAL CANCER RESEARCH

Cancer Stem Cells and the Ontogeny of Lung Cancer

(2008) Craig D. Peacock et al.   JOURNAL OF CLINICAL ONCOLOGY

Oct-4 Expression Maintained Cancer Stem-Like Properties in Lung Cancer-Derived CD133-Positive Cells

(2008) Yu-Chih Chen et al.   PLoS One